Page last updated: 2024-10-30

mesoridazine and Long QT Syndrome

mesoridazine has been researched along with Long QT Syndrome in 4 studies

Mesoridazine: A phenothiazine antipsychotic with effects similar to CHLORPROMAZINE.
mesoridazine : A phenothiazine substituted at position 2 (para to the S atom) by a methylsulfinyl group, and on the nitrogen by a 2-(1-methylpiperidin-2-yl)ethyl group.

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cappuccio, C1
Salih, IS1
Thanacoody, RH2
McKay, GA1
Thomas, SH2
Daly, AK1
Reilly, JG1
Ferrier, IN1
Dallaire, S1

Trials

1 trial available for mesoridazine and Long QT Syndrome

ArticleYear
Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:5

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Area Under Curve; Cross-Over Studies; Dopamine An

2007

Other Studies

3 other studies available for mesoridazine and Long QT Syndrome

ArticleYear
Medications that prolong the QT interval.
    JAMA, 2003, Aug-27, Volume: 290, Issue:8

    Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Mesoridazine; Risk

2003
Factors affecting drug concentrations and QT interval during thioridazine therapy.
    Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:5

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alleles; Antipsychotic Agents; Aryl Hydrocarbon Hydroxy

2007
Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Jan-09, Volume: 164, Issue:1

    Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Contraindications; Heart Conduction System; Humans; Long

2001